The global life sciences BPO market size was estimated at USD 397.75 billion in 2023 and it is expected to reach around USD 795.08 billion by 2032, poised to grow at a compound annual growth rate (CAGR) of 8% during the forecast period 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The Asia Pacific life sciences BPO market size was valued at USD 153.25 billion in 2023 and is expected to reach USD 301.26 billion by 2032, growing at a CAGR of 7.80% from 2023 to 2032.
On the basis of geography, the region of North America has gained the top most position in the life sciences with increased development of drug, with increased government support with policies such as reimbursement, increased manufacturing and costing of the drugs and medical devices and treatments. Which expands the market to greater extent.
Second highest region to hold the market of life sciences BPO is Europe region countries involved are Sweden, the UK, and Germany with developed technologies and developments in advanced health care centers have driven the market to grow high.
Third highest region is Asia Pacific region with increased revenue share globally and rise of the market countries involved are India, China, Japan, increased government attention towards the development of life science process, other regions such as Latin America and Middle East and Africa have low market share with low infrastructure affect the market growth and decreased market rate of life sciences.
Life Sciences BPO Market Share, By Region, 2022 (%)
| Regions | Revenue Share in 2022 (%) |
| North America | 27.50% |
| Asia Pacific | 38.60% |
| Europe | 22% |
| Latin America | 8% |
| MEA | 3.90% |
Life sciences organizations and companies have increased the massive developments and productions with the good productivity in the health sectors which help to boost the market growth during the forecast period. The life sciences BPO involves study and research of development and manufacturing of the pharmaceuticals, medical devices, bio-medical technologies, biotechnology based food and medicines, nutraceuticals, cosmecuticals, food processing and other products to increase the productions and manufacturing with the improved clinical trials and safety of the products. Impact of Covid-19 the pandemic situation is affected to a greater extent with the increased market growth of life sciences BPO, increased demands from the health sector in pandemic situation for covid-19 testing kits and for the development and trials of the vaccines.
The significant growth of the life sciences BPO market to increase day by day due to increased chronic disorders such as cancer, tuberculosis, infectious disease and many more affected the market to grow. Decreased Covid-19 cases with increased vaccination drives the market to a greater extent. Increased adapting of the new innovative technologies and development of the drug and safety of the drug with performed clinical trials and increased production and development with good productivity.
Increased research and development process for developing and manufacturing new drug having higher efficacy and safety. In life sciences companies take advantages of data management with decreased costing of the products with improved solutions and services with the machine learning and performing the task over a software using cloud technology.
Pharmacovigilance is the major role for showing the life science future with the massive growth of the market. Increased activities in the pharmaceutical companies with higher efficiency and efficacy to develop the drug with improved clinical trials, research and development activities and safety of the drug to avoid the adverse reactions of the drug. The key market players involved in introducing, manufacturing, producing and developing new methods and technologies have helped to boost the market to grow.
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 8% |
| Market Size in 2023 | USD 397.75 Billion |
| Market Size by 2032 | USD 795.08 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 8% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Services, Application, Protocol and Geography |
| Companies Mentioned |
International Business Machines Corp, IOVIA, PAREXEL International Corp, Lonza Group, Infosys.Ltd, ICON plc, Genpact LTD, Covance, Inc. (Labcorp), Catalent, Inc, Boehringer Ingelheim Gmbh, Atos SE, Accenture plc, Syneos Health, Inc, Charkes River Laboratories International, Inc, Wuxi AppTec Co, Ltd, Medpace Holdings, Inc, PRA Health Sciences, Inc, Cognizant Technology Solutions, Quintiles Transactional Corporation, and Others |
Market Drivers
The increasing life sciences BPO market with increased research and development process with increased strategies of outsourcing plays a major role in pharmaceutical companies. Strategic out sourcing has become the important factor in the development in industries with multiple facilities from screening of the drugs to determining the lead toxicology, preclinical studies, clinical studies, clinical trials, manufacturing and marketing.
In developing new pharmaceutical outsourcing market. CMOs and CROs are involved in last few years which have contributed for the growth of the life sciences market. Outsourcing has become the important strategy door pharmaceutical development, biotechnology development in life sciences industries, and transfer of non-core activities to outsourcing. Increased focused on distribution networking, market strategies, research and development have raised the market growth.
Increased productivity and with the increased safety have thrived the market to grow. The market players involved in the life sciences for introducing new developments have contributed to boost the market growth to a larger extent.
Market Challenges
The major factor that challenges the growth of life sciences market as per investigation of the life sciences market lack of awareness among the people and lack of skill work is required along with the developments and new features updates, new procedures and clinical work to be performed required professional skill work. Lack of skill may hamper the growth of the life sciences BPO market during the forecast period.
Audience being targeted belong to regions which are the involved in the global market which differ in income sources and capacity of investing. Increased investing in the production and development of the new drug developments and increased research and clinical trials in different countries with same drug is also the challenging task for the market to grow.
Out sourcing of drugs to various countries which involves different guidelines a regulatory process for drug, filing, clinical trials. Involved market players in introducing new developments and technologies have increased the market revenue share during the forecast period.
Market Opportunities
Pharmaceutical Outsourcing - Increasing life sciences BPO with various developments have raised the market multiples segments involved in the market for rising the growth of the market. Which involves contract manufacturing of the market such as for production active pharmaceutical ingredient is the major role for developing and discovering drug with various formulations available and for developing the dosage form with higher efficacy and no adverse reactions and finally producing the dosage form and packaging done. Contract research organization involves discovery of the drug and clinical trials are done such preclinical studies and clinical trials studies, clinical trial I, II, III, IV to study the efficacy and safety of the drug in limited population the study is performed, Regulatory services and pharmacovigilance have increased the market of life sciences.
Medical Deceives Outsourcing - Increased services in life sciences have raised the market to enhance the requirements and increased research. Medical devices outsourcing involves contract manufacturing market such as electronic manufacturing services required in patients’ health care safety with increased production of medical devices with developed technologies and research development process, finished goods process, raw materials components.
Segmentation of life sciences BPO on the basis of application wide utilization of life sciences in various sectors in pharmaceutical development of various drugs which is the most widely adapted in the current world due to increasing chronic disorders and utilization of medical devices in health care center and utilization in biopharmaceuticals. Hospitals and clinics are the major role players for development of the life science market with increased research and developments have enhanced the market of life sciences to a greater extent.
Segments covered in the report
By Services
By Application
By Protocol
By Geography
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
